Current Status of Bill HR 5882
Bill HR 5882 is currently in the status of Bill Introduced since February 12, 2020. Bill HR 5882 was introduced during Congress 116 and was introduced to the House on February 12, 2020. Bill HR 5882's most recent activity was Referred to the House Committee on Energy and Commerce. as of February 12, 2020
Bipartisan Support of Bill HR 5882
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
6Democrat Cosponsors
2Republican Cosponsors
4Unaffiliated Cosponsors
0
Policy Area and Potential Impact of Bill HR 5882
Primary Policy Focus
HealthPotential Impact Areas
Administrative law and regulatory proceduresAppropriationsCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyGeneticsGovernment studies and investigationsHealth care costs and insuranceHome and outpatient careIntergovernmental relationsManufacturingMedicaidPrescription drugsState and local government operations
Alternate Title(s) of Bill HR 5882
GENE Therapy Payment ActTo amend title XIX of the Social Security Act to provide States with the option under the Medicaid program to pay for covered outpatient drugs through risk-sharing value-based agreements, and for other purposes.GENE Therapy Payment ActGenerating Effective and Novel Evidence for Therapy Payment Act